» Articles » PMID: 7502042

Fas Ligand-induced Apoptosis As a Mechanism of Immune Privilege

Overview
Journal Science
Specialty Science
Date 1995 Nov 17
PMID 7502042
Citations 466
Authors
Affiliations
Soon will be listed here.
Abstract

The eye is a privileged site that cannot tolerate destructive inflammatory responses. Inflammatory cells entering the anterior chamber of the eye in response to viral infection underwent apoptosis that was dependent on Fas (CD95)-Fas ligand (FasL) and produced no tissue damage. In contrast, viral infection in gld mice, which lack functional FasL, resulted in an inflammation and invasion of ocular tissue without apoptosis. Fas-positive but not Fas-negative tumor cells were killed by apoptosis when placed within isolated anterior segments of the eyes of normal but not FasL-negative mice. FasL messenger RNA and protein were detectable in the eye. Thus, Fas-FasL interactions appear to be an important mechanism for the maintenance of immune privilege.

Citing Articles

Current Perspectives of TLR2 Signalling in the Retina.

Dalton R, Doyle S Adv Exp Med Biol. 2025; 1468:127-131.

PMID: 39930184 DOI: 10.1007/978-3-031-76550-6_21.


Decoding the mechanisms behind second primary cancers.

Zeng M, Lin A, Jiang A, Qiu Z, Zhang H, Chen S J Transl Med. 2025; 23(1):115.

PMID: 39856672 PMC: 11762917. DOI: 10.1186/s12967-025-06151-9.


miRNA-431-5p enriched in EVs derived from IFN-β stimulated MSCs potently inhibited ZIKV through CD95 downregulation.

Yuan M, Tian X, Ma W, Zhang R, Zou X, Jin Y Stem Cell Res Ther. 2024; 15(1):435.

PMID: 39563434 PMC: 11575116. DOI: 10.1186/s13287-024-04040-4.


Unveiling the role of Pleckstrin-2 in tumor progression and immune modulation: insights from a comprehensive pan-cancer analysis with focus on lung cancer.

Yin E, Liu C, Yao Y, Luo Y, Yang Y, Tang X Mol Biomed. 2024; 5(1):59.

PMID: 39546161 PMC: 11568116. DOI: 10.1186/s43556-024-00225-8.


Convergent inducers and effectors of T cell paralysis in the tumour microenvironment.

Hanahan D, Michielin O, Pittet M Nat Rev Cancer. 2024; 25(1):41-58.

PMID: 39448877 DOI: 10.1038/s41568-024-00761-z.